The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Desmoid fibromatosis and pregnancy: A multi-institutional analysis of recurrence and obstetric risk.
Marco Fiore
No relevant relationships to disclose
Sara Coppola
No relevant relationships to disclose
Chiara Colombo
No relevant relationships to disclose
Monica M. Bertagnolli
No relevant relationships to disclose
Suzanne George
No relevant relationships to disclose
Axel Le Cesne
Honoraria - Novartis; Pfizer; PharmaMar
Paolo Giovanni Casali
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Infinity; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar; Sanofi
Honoraria - Novartis; Pfizer; PharmaMar
Research Funding - Amgen Dompé; Bayer; GlaxoSmithKline; ImClone Systems; Infinity; Lilly; Merck Sharp & Dohme; MolMed S.p.A.; Novartis; Pfizer; PharmaMar; Sanofi ; Schering-Plough
Other Remuneration - Novartis; PharmaMar
Alessandro Gronchi
No relevant relationships to disclose
Sylvie Bonvalot
Honoraria - Novartis
Research Funding - Novartis; PharmaMar
Chandrajit P. Raut
Honoraria - Novartis